Search Results - "Tullio, F."

Refine Results
  1. 1

    Modeling and Simulating Wind Energy Generation Systems by Means of Co-Simulation Techniques by da Silva, Loan Tullio F. W., Tomim, Marcelo Aroca, Barbosa, Pedro Gomes, de Almeida, Pedro Machado, da Silva Dias, Robson Francisco

    Published in Energies (Basel) (01-10-2023)
    “…This paper presents the development of a wind energy conversion system co-simulation based on the Functional Mock-up Interface standard aiming at contributing…”
    Get full text
    Journal Article
  2. 2

    Monosized Polymeric Microspheres Designed for Passive Lung Targeting: Biodistribution and Pharmacokinetics after Intravenous Administration by Agnoletti, Monica, Rodríguez-Rodríguez, Cristina, Kłodzińska, Sylvia N, Esposito, Tullio V. F, Saatchi, Katayoun, Mørck Nielsen, Hanne, Häfeli, Urs O

    Published in ACS nano (23-06-2020)
    “…Local as well as systemic therapy is often used to treat bacterial lung infections. Delivery of antibiotics to the vascular side of infected lung tissue using…”
    Get full text
    Journal Article
  3. 3

    Hybrid Metal–Phenol Nanoparticles with Polydopamine-like Coating for PET/SPECT/CT Imaging by Suárez-García, Salvio, Esposito, Tullio V. F, Neufeld-Peters, Jenna, Bergamo, Marta, Yang, Hua, Saatchi, Katayoun, Schaffer, Paul, Häfeli, Urs O, Ruiz-Molina, Daniel, Rodríguez-Rodríguez, Cristina, Novio, Fernando

    Published in ACS applied materials & interfaces (10-03-2021)
    “…The validation of metal–phenolic nanoparticles (MPNs) in preclinical imaging studies represents a growing field of interest due to their versatility in forming…”
    Get full text
    Journal Article
  4. 4

    Optimization strategies for HIV, hepatitis and syphilis testing in Infectious Disease Clinic and Dermatology Unit of Modena: 7‐year results of collaboration experience by Mandel, V.D., Di Tullio, F., Rugge, W., Coppini, M., Mussini, C., Pellacani, G., Borghi, V.

    “…Background Screening tests for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and syphilis infections performed in…”
    Get full text
    Journal Article
  5. 5

    Diazoxide postconditioning induces mitochondrial protein S-Nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements: no role for SAFE by Penna, C., Perrelli, M.-G., Tullio, F., Angotti, C., Camporeale, A., Poli, V., Pagliaro, P.

    Published in Basic research in cardiology (01-09-2013)
    “…Postconditioning (PostC) can be obtained either with brief cycles of ischemia/reperfusion (I-PostC) or with a direct targeting of mitochondria with Diazoxide…”
    Get full text
    Journal Article
  6. 6

    Preparation of Heat-Denatured Macroaggregated Albumin for Biomedical Applications Using a Microfluidics Platform by Esposito, Tullio V. F, Stütz, Helene, Rodríguez-Rodríguez, Cristina, Bergamo, Marta, Charles, Lovelyn, Geczy, Reka, Blackadar, Colin, Kutter, Jörg P, Saatchi, Katayoun, Häfeli, Urs O

    Published in ACS biomaterials science & engineering (14-06-2021)
    “…Albumin is widely used in pharmaceutical applications to alter the pharmacokinetic profile, improve efficacy, or decrease the toxicity of active compounds…”
    Get full text
    Journal Article
  7. 7

    Cardioprotection against ischemia/reperfusion injury and chromogranin A-derived peptides by Penna, C, Tullio, F, Perrelli, M-G, Mancardi, D, Pagliaro, P

    Published in Current medicinal chemistry (2012)
    “…Chromogranin A (CgA) is produced by cells of the sympathoadrenal system and by human ventricular myocardium. In the clinical setting CgA has been mainly used…”
    Get more information
    Journal Article
  8. 8

    Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats by Penna, C., Tullio, F., Perrelli, M.-G., Moro, F., Abbadessa, G., Piccione, F., Carriero, V., Racca, S., Pagliaro, P.

    Published in Basic research in cardiology (01-05-2011)
    “…We hypothesized that nandrolone (ND)-abuse induces cardiac hypertrophy, increases myocardial susceptibility to ischemia/reperfusion (I/R) injury, and reduces…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Biodistribution of the cationic host defense peptide LL-37 using SPECT/CT by Esposito, Tullio V.F., Rodríguez-Rodríguez, Cristina, Blackadar, Colin, Kłodzińska, Sylvia, Mørck Nielsen, Hanne, Saatchi, Katayoun, Häfeli, Urs O.

    “…[Display omitted] Human cathelicidin LL-37, a cationic host defense peptide (CHDP), has several important physiological roles, including antimicrobial…”
    Get full text
    Journal Article
  14. 14

    Post-ischaemic activation of kinases in the pre-conditioning-like cardioprotective effect of the platelet-activating factor by Penna, C, Mognetti, B, Tullio, F, Gattullo, D, Mancardi, D, Moro, F, Pagliaro, P, Alloatti, G

    Published in Acta Physiologica (01-11-2009)
    “…Platelet-activating factor (PAF) triggers cardiac pre-conditioning against ischemia/reperfusion injury. The actual protection of ischaemic pre-conditioning…”
    Get full text
    Journal Article
  15. 15

    Biodistribution of Native and Nanoformulated Innate Defense Regulator Peptide 1002 by Esposito, Tullio V. F., Blackadar, Colin, Wu, Lan, Rodríguez-Rodríguez, Cristina, Haney, Evan F., Pletzer, Daniel, Saatchi, Katayoun, Hancock, Robert E. W., Häfeli, Urs O.

    Published in Molecular pharmaceutics (03-06-2024)
    “…Innate defense regulator-1002 (IDR-1002) is a synthetic peptide with promising immunomodulatory and antibiofilm properties. An appreciable body of work exists…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Biodistribution and toxicity of innate defense regulator 1018 (IDR-1018) by Esposito, Tullio V.F., Rodríguez-Rodríguez, Cristina, Blackadar, Colin, Haney, Evan F., Pletzer, Daniel, Hancock, Robert E.W., Saatchi, Katayoun, Häfeli, Urs O.

    “…[Display omitted] Innate defense regulators (IDRs) are synthetic host-defense peptides (HDPs) with broad-spectrum anti-infective properties, including…”
    Get full text
    Journal Article
  18. 18

    Prospective audit of short-term concurrent ketamine, opioid and anti-inflammatory ('triple-agent') therapy for episodes of acute on chronic pain by Good, P., Tullio, F., Jackson, K., Goodchild, C., Ashby, M.

    Published in Internal medicine journal (01-01-2005)
    “…Aim:  This prospective audit was undertaken in order to document the analgesic response and adverse effects of concurrent short‐term (‘burst’) triple‐agent…”
    Get full text
    Journal Article
  19. 19
  20. 20